| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | 16,708 | 13,164* | 11,756 | 11,013 |
| Cost of goods sold | 3,722 | 2,993* | 2,795 | 2,620 |
| Gross profit | 12,986 | 10,171* | 8,961 | 8,393 |
| Selling, general and administrative expenses (includes 1,239 and 849 to related parties, respectively) | 18,208 | 12,879* | 15,077 | 12,849 |
| Research and development expenses (includes 3,065 and 1,235 to related parties, respectively) | 3,754 | 3,335* | 1,525 | 1,406 |
| Operating loss | -8,976 | -6,042* | -7,641 | -5,862 |
| Interest (income) expense, net | -436 | -371* | 78 | 216 |
| Change in fair value of convertible notes, net | NaN | -4,434* | 2,217 | NaN |
| Change in fair value of series e purchase option | NaN | -2,535* | 0 | 11,719 |
| Other (income) expense, net | 161 | 232* | 1,207 | -1,399 |
| Total other (income) expense | 597 | 7,572* | -1,088 | -13,334 |
| Gain before income tax expense | -8,379 | 1,529* | -8,729 | -19,196 |
| Computed expected tax benefit | NaN | -2,119* | NaN | NaN |
| Permanent differences | NaN | 13* | NaN | NaN |
| General business tax credits | NaN | 57* | NaN | NaN |
| Other | NaN | -207* | NaN | NaN |
| Change in valuation allowance | NaN | 2,370* | NaN | NaN |
| Income tax expense | 0 | 0* | 0 | 0 |
| Net gain | -8,379 | 1,529* | -8,729 | -19,196 |
| Unrealized loss on marketable securities | -181 | -17 | -43 | 1 |
| Total other comprehensive loss, net | -181 | -17* | -43 | 1 |
| Comprehensive gain | -8,560 | 1,512 | -8,772 | -19,195 |
| Basic EPS | -0.41 | 0.174 | -0.64 | -165.53 |
| Diluted EPS | -0.41 | 0.174 | -0.64 | -165.53 |
| Basic Average Shares | 20,653,035 | 8,673,148* | 13,604,556 | 115,965 |
| Diluted Average Shares | 20,653,035 | 8,673,148* | 13,604,556 | 115,965 |
SHOULDER INNOVATIONS, INC. (SI)
SHOULDER INNOVATIONS, INC. (SI)